Overall rank by patents
#40,880
of 49,997 tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Imunami Laboratories Pte. Ltd.
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2018–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Imunami ranks #40,880 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
- #40,880
- of 49,997 US assignees by volume
- 6th percentile
- by Innovation Score (19.6/100)
- 11.2
- avg claims per patent
- -80%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40880 · Foreign Corporation #40,880 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,880/49,997
- PHOTO-FINISH Imnate Sarl
- CPC-NARROW A61P · 3 areas
- INNOV-LOW 19.6/100
- CLAIMS-PAR 11.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -80% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Imnate Sarl (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Innovation-score neighbourhood around Imunami
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Gymworld · near 20
Gymworld · near
20 score
- Jacuzzi · near 20
Jacuzzi · near
20 score
- Imunami Laboratories… · this assignee 20
Imunami Laboratories… · this assignee
20 score
- Think Tank Photo · near 20
Think Tank Photo · near
20 score
- Wittenstein · near 20
Wittenstein · near
20 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Imunami's Innovation Score is 19.6/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Where Imunami's grants concentrate
Imunami Laboratories Pte. Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2018. By volume, Imunami sits between Imnate Sarl and Indexator Rotator Systems AB.
Who files at Imunami's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Imnate Sarl
Imnate Sarl
6 patents
- Impossible Diamond
Impossible Diamond, Inc.
6 patents
- Impress Group B V
Impress Group B.V.
6 patents
- Improved Racing P…
Improved Racing Products, LLC
6 patents
- Inevit
InEVit LLC
6 patents
- Insyte Systems
InSyte Systems, Inc.
6 patents
- Incuron
Incuron, Inc.
6 patents
- Indexator Rotator…
Indexator Rotator Systems AB
6 patents
- Imunami Laborator… ◀
Imunami Laboratories Pte. Ltd.
6 patents
What this shows Imunami holds 6 patents at rank #40,962, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Imunami
By rank, the assignees closest to #40,962 in granted patent volume.
- Imnate Sarl #40,958 · 6 patents
- Impossible Diamond, Inc. #40,959 · 6 patents
- Impress Group B.V. #40,960 · 6 patents
- Improved Racing Products, LLC #40,961 · 6 patents
- InEVit LLC #40,963 · 6 patents
- InSyte Systems, Inc. #40,964 · 6 patents
- Incuron, Inc. #40,965 · 6 patents
- Indexator Rotator Systems AB #40,966 · 6 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Imunami's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Imunami, neither rank-band nor same-CPC leaders (those blocks stay above).
Similar innovation score
Nearest assignees by Innovation Score (20 here).
Imunami's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
20 6th percentile higher than 6% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 16.7% |
| 2019 | 4 | 66.7% |
| 2020 | 1 | 16.7% |
Which technologies does Imunami Laboratories Pte. Ltd. patent most?
Top 3 of 3 technology areas
What to do with this data
Imunami Laboratories Pte. Ltd.'s patent record in context - here's where to go next.
- Imunami Laboratories Pte. Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #40,880 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Imunami Laboratories Pte. Ltd. against Imnate Sarl, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 19.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.